Company / Assets per Share
Amylyx Pharmaceuticals, Inc. Assets per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$3.03
FY2025
5-year range
$2.82 / $55.76
FY2021-FY2025
Trend
+7.3%
vs FY2024
Sector context
#173 of 210
Health Care
What the data says
Amylyx Pharmaceuticals, Inc.'s assets per share of $3.03 is lower than 82% of companies in the Health Care sector (FY2025). Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $3.03.
Based on SEC 10-K filings.
3.03 in FY2025 with a 3-year CAGR of -62.1%.
Declined from $7.64 to $3.03 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -62.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 210This company $3.03 Sector average $353.15
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 7.3% year-over-year.
- Ranks #173 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.03 | +7.3% |
| FY2024 | $2.82 | -63.1% |
| FY2023 | $7.64 | -86.3% |
| FY2022 | $55.76 | +247.7% |
| FY2021 | $16.04 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026